By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AB Science 

3, Avenue George V

Paris    75008  France
Phone: 33-(0)1-47200014 Fax: 33-(0)1-47202411


SEARCH JOBS


Industry
Pharmaceutical






Company News
AB Science (AB.PA): The Data And Safety Monitoring Board Recommends The Continuation Of The Phase 2 Study With Masitinib In Advanced Hepatocellular Carcinoma 11/12/2014 10:30:17 AM
AB Science (AB.PA): Masitinib In Mastocytosis - Summary Of Web Conference 11/10/2014 10:01:22 AM
AB Science (AB.PA): Web Conference On Masitinib In Mastocytosis 11/3/2014 8:28:41 AM
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014 7:23:56 AM
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/21/2014 8:51:42 AM
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/20/2014 8:58:25 AM
AB Science (AB.PA) Announces Initiation Of A New Phase 3 Study In Oncology With Masitinib In Patients With Metastatic Colorectal Cancer 12/3/2013 9:46:01 AM
AB Science (AB.PA): Final Results Of Phase 3 Mastocytosis Study Expected By End Of 2014 11/12/2013 1:36:49 PM
AB Science (AB.PA): Masitinib Successfully Passes Futility Analysis in Pivotal Clinical Study in Mastocytosis 11/11/2013 11:30:16 AM
AB Science (AB.PA) Release: Masitinib is Being Investigated in the Treatment of Amyotrophic Lateral Sclerosis (ALS) 11/5/2013 9:53:45 AM
123
//-->